iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Panacea Biotec hits the roof on bagging $127 mn orders from UNICEF, PAHO

11 Oct 2022 , 09:21 AM

The contract is for the supply of WHO pre-qualified fully liquid Pentavalent vaccine, Easyfive-TT (DTwP-HepB-Hib). UNICEF award is worth $98.755 million (approximately Rs 813 crore) for supply of approximately 99.70 million doses during calendar years 2023-2027 and PAHO award is worth $28.55 million (approximately Rs 235 crore) for supply approximately 24.83 million doses during calendar years 2023-2025. Paediatric vaccination plays an important role to achieve Sustainable Development Goals (SDGs) set by the United Nations, in particular the target to reduce under-five mortality rate to less than 25 per 1000 live births. Pentavalent vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections caused by Haemophilus Influenza Type b – becoming the foundation of paediatric immunization programs across the world. Easyfive-TT is the worlds first fully liquid wP-based Pentavalent vaccine that as launched in India in 2005. After receiving WHO prequalification in 2008, more than 150 million doses have been supplied to over 75 countries globally. Dr. Rajesh Jain, Managing Director, Panacea Biotec said, We are delighted to receive the notification of UNICEF and PAHO awards for Pentavalent vaccine at this important juncture in Panacea Biotecs journey.? Panacea Biotec is a biotechnology company that focuses on discovery, development, and commercialisation of prescription medicines primarily, focusing on vaccines, diabetes, transplant, gastroenterology, and oncology. The company reported a consolidated net loss of Rs 56.14 crore in Q1 FY23 as against a net loss of Rs 57.35 crore recorded in Q1 FY22. Net sales dropped 16.4% year on year to Rs 110.70 crore in Q1 FY23.Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.